DAVID P. LUCI - 23 Feb 2024 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Kostantinos Skordalos, Power of Attorney For: David P. Luci
Issuer symbol
ACXP
Transactions as of
23 Feb 2024
Transactions value $
$0
Form type
4
Filing time
03 Apr 2024, 21:56:33 UTC
Previous filing
04 Jan 2024
Next filing
08 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACXP Stock Option Award $0 +250,000 $0 250,000 23 Feb 2024 Common Stock 250,000 $3.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 23, 2024 (the "Grant Date"), the Reporting Person was granted stock options to purchase 250,000 shares of the Issuer's common stock. These options vest in 36 equal monthly installments commencing on the Grant Date. This transaction is late due to an inadvertent administrative error and not any error of the Reporting Person.